Monotherapy in Patients with Type 2 Diabetes Mellitus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rhee, Sang Youl | - |
dc.contributor.author | Kim, Hyun Jin | - |
dc.contributor.author | Ko, Seung-Hyun | - |
dc.contributor.author | Hur, Kyu-Yeon | - |
dc.contributor.author | Kim, Nan-Hee | - |
dc.contributor.author | Moon, Min Kyong | - |
dc.contributor.author | Park, Seok-O | - |
dc.contributor.author | Lee, Byung-Wan | - |
dc.contributor.author | Choi, Kyung Mook | - |
dc.contributor.author | Kim, Jin Hwa | - |
dc.date.accessioned | 2021-09-03T00:21:45Z | - |
dc.date.available | 2021-09-03T00:21:45Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2017-10 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/81995 | - |
dc.description.abstract | In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN DIABETES ASSOC | - |
dc.subject | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | - |
dc.subject | GLUCOSE-LOWERING EFFICACY | - |
dc.subject | LONG-TERM METFORMIN | - |
dc.subject | CARDIOVASCULAR OUTCOMES | - |
dc.subject | POSITION STATEMENT | - |
dc.subject | PREVENTION PROGRAM | - |
dc.subject | GLYCEMIC CONTROL | - |
dc.subject | BLOOD-GLUCOSE | - |
dc.subject | LIFE-STYLE | - |
dc.subject | METAANALYSIS | - |
dc.title | Monotherapy in Patients with Type 2 Diabetes Mellitus | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Nan-Hee | - |
dc.contributor.affiliatedAuthor | Choi, Kyung Mook | - |
dc.identifier.doi | 10.4093/dmj.2017.41.5.349 | - |
dc.identifier.wosid | 000415367400003 | - |
dc.identifier.bibliographicCitation | DIABETES & METABOLISM JOURNAL, v.41, no.5, pp.349 - 356 | - |
dc.relation.isPartOf | DIABETES & METABOLISM JOURNAL | - |
dc.citation.title | DIABETES & METABOLISM JOURNAL | - |
dc.citation.volume | 41 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 349 | - |
dc.citation.endPage | 356 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002276498 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | - |
dc.subject.keywordPlus | GLUCOSE-LOWERING EFFICACY | - |
dc.subject.keywordPlus | LONG-TERM METFORMIN | - |
dc.subject.keywordPlus | CARDIOVASCULAR OUTCOMES | - |
dc.subject.keywordPlus | POSITION STATEMENT | - |
dc.subject.keywordPlus | PREVENTION PROGRAM | - |
dc.subject.keywordPlus | GLYCEMIC CONTROL | - |
dc.subject.keywordPlus | BLOOD-GLUCOSE | - |
dc.subject.keywordPlus | LIFE-STYLE | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordAuthor | Diabetes mellitus, type 2 | - |
dc.subject.keywordAuthor | Hypoglycemic agents | - |
dc.subject.keywordAuthor | Metformin | - |
dc.subject.keywordAuthor | Practice guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.